Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 9 | 2022 | 871 | 1.950 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 2023 | 88 | 1.430 |
Why?
|
| Death, Sudden | 2 | 2016 | 45 | 0.970 |
Why?
|
| Epilepsies, Partial | 4 | 2020 | 91 | 0.960 |
Why?
|
| Epilepsy, Generalized | 2 | 2020 | 64 | 0.740 |
Why?
|
| Spasms, Infantile | 1 | 2022 | 171 | 0.700 |
Why?
|
| Periventricular Nodular Heterotopia | 1 | 2019 | 8 | 0.660 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2018 | 71 | 0.590 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 545 | 0.510 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2016 | 3154 | 0.500 |
Why?
|
| Sudden Infant Death | 1 | 2016 | 32 | 0.500 |
Why?
|
| Cognition Disorders | 1 | 2018 | 553 | 0.460 |
Why?
|
| Penetrance | 1 | 2014 | 102 | 0.450 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2016 | 257 | 0.420 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2016 | 459 | 0.390 |
Why?
|
| Brain | 1 | 2019 | 2982 | 0.280 |
Why?
|
| Heterozygote | 3 | 2019 | 671 | 0.260 |
Why?
|
| Seizures | 2 | 2020 | 872 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2006 | 369 | 0.220 |
Why?
|
| Chromosome Deletion | 1 | 2006 | 647 | 0.200 |
Why?
|
| Glycosylation | 1 | 2022 | 120 | 0.200 |
Why?
|
| Temporal Lobe | 1 | 2023 | 111 | 0.200 |
Why?
|
| Mutation | 1 | 2014 | 5825 | 0.180 |
Why?
|
| Abnormalities, Multiple | 2 | 2007 | 960 | 0.180 |
Why?
|
| Implantable Neurostimulators | 1 | 2020 | 18 | 0.170 |
Why?
|
| Humans | 16 | 2023 | 124725 | 0.170 |
Why?
|
| Brain Stem | 1 | 2020 | 115 | 0.170 |
Why?
|
| Electric Stimulation Therapy | 1 | 2020 | 103 | 0.160 |
Why?
|
| Dynamins | 1 | 2019 | 38 | 0.160 |
Why?
|
| Hippocampus | 2 | 2023 | 818 | 0.160 |
Why?
|
| Electrodes, Implanted | 1 | 2019 | 169 | 0.150 |
Why?
|
| Intellectual Disability | 1 | 2006 | 1056 | 0.150 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2020 | 204 | 0.140 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 5161 | 0.130 |
Why?
|
| Adult | 8 | 2020 | 29488 | 0.130 |
Why?
|
| Brain Diseases | 1 | 2019 | 299 | 0.130 |
Why?
|
| ERG1 Potassium Channel | 1 | 2016 | 4 | 0.130 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2016 | 6 | 0.130 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2016 | 11 | 0.130 |
Why?
|
| NAV1.1 Voltage-Gated Sodium Channel | 1 | 2016 | 14 | 0.130 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2016 | 13 | 0.130 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2016 | 36 | 0.130 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2016 | 37 | 0.120 |
Why?
|
| Infant | 3 | 2018 | 12475 | 0.120 |
Why?
|
| Potassium Channels | 1 | 2016 | 157 | 0.120 |
Why?
|
| Male | 9 | 2020 | 61269 | 0.110 |
Why?
|
| Brain Chemistry | 1 | 2013 | 122 | 0.100 |
Why?
|
| Chloride Channels | 1 | 2013 | 62 | 0.100 |
Why?
|
| Young Adult | 4 | 2020 | 9023 | 0.090 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2012 | 153 | 0.090 |
Why?
|
| Adolescent | 5 | 2020 | 19284 | 0.090 |
Why?
|
| Quality of Life | 1 | 2020 | 1935 | 0.090 |
Why?
|
| Ion Channels | 1 | 2011 | 190 | 0.080 |
Why?
|
| Deep Brain Stimulation | 1 | 2015 | 408 | 0.080 |
Why?
|
| Female | 9 | 2020 | 66569 | 0.080 |
Why?
|
| Information Dissemination | 1 | 2011 | 186 | 0.080 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 3716 | 0.080 |
Why?
|
| Ethics, Medical | 1 | 2011 | 395 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2018 | 14018 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 3556 | 0.070 |
Why?
|
| Stroke | 1 | 2015 | 986 | 0.070 |
Why?
|
| DNA | 1 | 2012 | 1597 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 4342 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2013 | 1497 | 0.060 |
Why?
|
| Psychomotor Performance | 1 | 2007 | 182 | 0.060 |
Why?
|
| Mutation, Missense | 3 | 2019 | 875 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2011 | 519 | 0.060 |
Why?
|
| Genetic Testing | 1 | 2012 | 1002 | 0.060 |
Why?
|
| Video Recording | 1 | 2006 | 182 | 0.060 |
Why?
|
| Electroencephalography | 2 | 2007 | 864 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 1701 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 2520 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2007 | 789 | 0.060 |
Why?
|
| Genomics | 1 | 2011 | 1501 | 0.050 |
Why?
|
| Child | 2 | 2018 | 24383 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2007 | 799 | 0.050 |
Why?
|
| Syndrome | 1 | 2006 | 1119 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2006 | 1079 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 2634 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2006 | 541 | 0.050 |
Why?
|
| Risk Factors | 1 | 2015 | 10286 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2018 | 16335 | 0.040 |
Why?
|
| Intracranial Hemorrhages | 1 | 2020 | 75 | 0.040 |
Why?
|
| Peroxisomes | 1 | 2019 | 36 | 0.040 |
Why?
|
| Muscles | 1 | 2019 | 289 | 0.040 |
Why?
|
| Status Epilepticus | 1 | 2020 | 144 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 143 | 0.040 |
Why?
|
| Animals | 3 | 2015 | 34024 | 0.040 |
Why?
|
| Prosthesis-Related Infections | 1 | 2020 | 177 | 0.040 |
Why?
|
| Suicide | 1 | 2020 | 169 | 0.040 |
Why?
|
| Memory Disorders | 1 | 2020 | 236 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2020 | 6147 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2020 | 450 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 1111 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 1613 | 0.030 |
Why?
|
| Mitochondria | 1 | 2019 | 681 | 0.030 |
Why?
|
| Aged | 3 | 2020 | 19764 | 0.030 |
Why?
|
| Quality Control | 1 | 2012 | 119 | 0.020 |
Why?
|
| Middle Aged | 3 | 2020 | 26797 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2020 | 12356 | 0.020 |
Why?
|
| Consent Forms | 1 | 2011 | 22 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2012 | 142 | 0.020 |
Why?
|
| Genetic Privacy | 1 | 2011 | 42 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2011 | 237 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2011 | 93 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2015 | 1640 | 0.020 |
Why?
|
| Informed Consent | 1 | 2011 | 334 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2011 | 646 | 0.020 |
Why?
|
| Autistic Disorder | 1 | 2011 | 342 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2013 | 2814 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2007 | 253 | 0.020 |
Why?
|
| Craniofacial Abnormalities | 1 | 2007 | 240 | 0.020 |
Why?
|
| Genome, Human | 1 | 2011 | 1273 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 6308 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 4806 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 1690 | 0.010 |
Why?
|
| Mice | 2 | 2013 | 17577 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 3447 | 0.010 |
Why?
|
| Neurons | 1 | 2011 | 1926 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 6548 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 3716 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 4375 | 0.010 |
Why?
|
| Phenotype | 1 | 2007 | 4255 | 0.010 |
Why?
|
| Neoplasms | 1 | 2011 | 2788 | 0.010 |
Why?
|